{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "An advisory committee of the Food and Drug Administration voted unanimously yesterday to recommend approval of the drug tamoxifen to reduce women's risk of developing breast cancer. Although the drug, which is already on the market, is intended only for women at high risk of breast cancer, and the advisory panel was cautious in its wording, tamoxifen's approval would be a milestone in efforts to prevent cancer.", "headline": {"main": "Drugs to Fight Breast Cancer Near Approval"}, "abstract": "Food and Drug Administration advisory committee votes unanimously to recommend approval of drug tamoxifen to reduce women's risk of developing breast cancer; tamoxifen's approval would be milestone in efforts to prevent cancer; drug, which is already on market, is intended only for women at high risk of breast cancer; advisory panel unanimously recommends approval for new drug, Herceptin, for women with advanced breast cancer; officials say drug is intended for use by estimated 30 percent of breast cancer patients who have too many copies of gene called HER2/neu, making cancer aggressively spread through body (M)", "print_page": "1", "word_count": 1931, "_id": "4fd1e1398eb7c8105d7294c4", "snippet": "An advisory committee of the Food and Drug Administration voted unanimously yesterday to recommend approval of the drug tamoxifen to reduce women's risk of developing breast cancer.    Although the drug, which is already on the market, is intended...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1998/09/03/us/drugs-to-fight-breast-cancer-near-approval.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "FOOD AND DRUG ADMINISTRATION"}, {"name": "subject", "value": "BREAST"}, {"name": "subject", "value": "GENETICS AND HEREDITY"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "CANCER"}, {"name": "subject", "value": "WOMEN"}, {"name": "subject", "value": "HER2/NEU (GENE)"}, {"name": "subject", "value": "TAMOXIFEN (DRUG)"}, {"name": "subject", "value": "HERCEPTIN (DRUG)"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Gina", "lastname": "KOLATA"}, {"organization": "", "role": "reported", "rank": 2}], "original": "By GINA KOLATA and LAWRENCE M. FISHER"}, "document_type": "article", "pub_date": "1998-09-03T00:00:00Z", "section_name": "Front Page; Health; U.S."}], "meta": {"hits": 1, "offset": 0, "time": 47}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}